CUTA Human Pre-designed siRNA Set A contains three designed siRNAs for CUTA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CUTC Human Pre-designed siRNA Set A contains three designed siRNAs for CUTC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CUX1 Human Pre-designed siRNA Set A contains three designed siRNAs for CUX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CUX2 Human Pre-designed siRNA Set A contains three designed siRNAs for CUX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CUZD1 Human Pre-designed siRNA Set A contains three designed siRNAs for CUZD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CVN293 is a selective and brain permeable potassium ion (K+) channel KCNK13 inhibtor with IC50s of 41 nM and 28 nM for hKCNK13 and mKCNK13, respectively. CVN293 potently inhibits the NLRP3-inflammasome mediated production of the proinflammatory cytokine IL-1β in microglia[1].

CVN766 is an orally active inhibitor of orexin 1 receptor antagonist with blood-brain permeability with the IC50 values of 8 nM and >10 μM for OX1R and OX2R, respectively. CVN766 can be used for study schizophrenia[1].

CW0134 (Compound 12) is a modulator for exportin1 (XPO1) ,which disrupts the chromatin binding, inhibits NFAT transcription factors and activation of T cells[1].

CW2158 (Compound 13) is a modulator for exportin1 (XPO1) ,which disrupts the chromatin binding, inhibits NFAT transcription factors and activation of T cells[1].

CWC15 Human Pre-designed siRNA Set A contains three designed siRNAs for CWC15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CWC22 Human Pre-designed siRNA Set A contains three designed siRNAs for CWC22 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CWC25 Human Pre-designed siRNA Set A contains three designed siRNAs for CWC25 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CWC27 Human Pre-designed siRNA Set A contains three designed siRNAs for CWC27 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CWF19L1 Human Pre-designed siRNA Set A contains three designed siRNAs for CWF19L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CWH43 Human Pre-designed siRNA Set A contains three designed siRNAs for CWH43 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CX3CL1 Human Pre-designed siRNA Set A contains three designed siRNAs for CX3CL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CX3CR1 Human Pre-designed siRNA Set A contains three designed siRNAs for CX3CR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cx3cr1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cx3cr1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cx3cr1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cx3cr1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXADR Human Pre-designed siRNA Set A contains three designed siRNAs for CXADR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL-CXCR1/2-IN-1 is an orally active ELR+CXCL-CXCR1/2 pathway inhibitor with an EC50 of 42.7 nM for CXCR2[1]. CXCL-CXCR1/2-IN-1 shows anticancer and antiangiogenic effects[1].

CXCL1 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL10 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL11 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL12 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL13 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL14 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL16 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL17 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL2 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL3 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL5 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL6 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL8 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL9 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCL9(74-103) is a derivative peptide of CXCL9 that has a high affinity for glycosaminoglycans (GAGs) and can bind to GAGs. CXCL9(74-103) possesses anti-angiogenic properties, capable of reducing EGF, VEGF165, and FGF-2-mediated angiogenesis processes in vitro, without exhibiting cytotoxicity[1].

CXCR1 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cxcr1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cxcr1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cxcr1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cxcr1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCR2 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cxcr2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cxcr2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCR2 Probe 1 (Compound [18F]16b) is a selective ligand for CXCR2 and is a radiotracer for PET imaging of neutrophils in inflammatory diseases[1].

Cxcr2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cxcr2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCR3 antagonist 1 (compound 6c) is a selective and non-cytotoxic CXCR3 antagonist (IC50=0.06 µM). CXCR3 antagonist 1 has potential in researching inflammatory diseases (including inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, and diabetes)[1].

CXCR3 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cxcr3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cxcr3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cxcr3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cxcr3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

CXCR4 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCR4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cxcr4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cxcr4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.